Xenon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update

9d ago, source: Business Insider

About Xenon Pharmaceuticals Inc. Xenon Pharmaceuticals (Nasdaq:XENE) is a neuroscience-focused biopharmaceutical company committed to discovering, developing, and commercializing innovative ...

Xenon Pharmaceuticals: Q1 Earnings Snapshot

9d ago, source: The Washington Post

BURNABY, British Columbia — BURNABY, British Columbia — Xenon Pharmaceuticals Inc. (XENE) on Thursday reported a loss of $47.9 million in its first quarter. The Burnaby, British Columbia-based ...

Xenon Pharmaceuticals to Present at the 2024 RBC Capital Markets Global Healthcare Conference

11d ago, source: Stockhouse

VANCOUVER, British Columbia, May 07, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience-focused biopharmaceutical company, today announced that the company will ...

Xenon Pharmaceuticals Inc. (XENE) Q1 2024 Earnings Call Transcript

9d ago, source: Seeking Alpha

At this time, I’d like to welcome everyone to the First Quarter 2024 Xenon Pharmaceuticals Incorporated Earnings Conference Call. All lines have been placed on mute to prevent any background noise ...

Xenon Pharmaceuticals: Q1 Earnings Snapshot

9d ago, source: Times Union

BURNABY, British Columbia (AP) — BURNABY, British Columbia (AP) — Xenon Pharmaceuticals Inc. (XENE) on Thursday reported a loss of $47.9 million in its first quarter. The Burnaby, British ...